Sensitive and specific serological ELISA for the detection of SARS-CoV-2 infections
SARS-CoV-2 감염 검출을 위한 민감하고 특이적인 혈청학적 ELISA
Article
[키워드] 113 patient
113 patients
95% CI
acute respiratory syndrome
acute respiratory syndrome coronavirus
acute respiratory syndrome coronavirus 2
antibody
antibody levels
Antibody titer
Antibody titers
approved
Asymptomatic
collected
coronavirus
coronavirus disease
Coronavirus disease 2019
Coronavirus disease 2019 (COVID-19)
COVID-19
cytomegalovirus
develop
early phase
ELISA
enzyme
enzyme-linked immunosorbent
enzyme-linked immunosorbent assay
Enzyme-linked immunosorbent assay (ELISA)
epidemiological data
Epstein Barr virus
Escherichia coli
Hepatitis
herpes simplex
herpes simplex virus
hospitalized COVID-19 patient
hospitalized COVID-19 patients
human serum
identify
IgG antibodies
IgG immune response
immune response
immunodeficiency
Infection
Mild
N-protein
nucleocapsid protein
Nucleocapsid protein (N-protein)
number of infected
pandemic
Pathogens
Patient
PCR
positive PCR test
produced
Protein
provided
purified
remained
RT-PCR
SARS-CoV-2
SARS-COV-2 infection
SARS-CoV-2 infections
SARS-CoV-2 nucleocapsid
SARS-CoV-2 specific antibodies
SARS-CoV-2 spike
sensitive
sensitivity
sera
serological
serological assays
serological test
serum sample
serum samples
severe acute respiratory syndrome Coronavirus
severe acute respiratory syndrome coronavirus 2
severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
severe symptom
severe symptoms
specific IgG antibody
specificity
symptom onset
symptomatic infections
tested
the SARS-CoV-2
triggered
Vaccine
virus
[DOI] 10.1186/s12985-022-01768-4 PMC 바로가기 [Article Type] Article
[DOI] 10.1186/s12985-022-01768-4 PMC 바로가기 [Article Type] Article